Episode 321 ASCO24: CHAARTED-2 in prostate cancer - is the sequel as good as the original?
The Uromigos - Un podcast de The Uromigos
Christos Kyriakopoulos describes the outcome of this study, where cabazitaxel with abiraterone as combined with abiraterone alone in docetaxel refractory CRPC.
